Response to Letters Regarding Article, “Evidence for Statin Pleiotropy in Humans: Differential Effects of Statins and Ezetimibe on Rho-Associated Coiled-Coil Containing Protein Kinase Activity, Endothelial Function, and Inflammation”
- 1 September 2009
- journal article
- letter
- Published by Wolters Kluwer Health in Circulation
- Vol. 120 (9)
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Statins inhibit Rho kinase activity in patients with atherosclerosisAtherosclerosis, 2009
- Evidence for Statin Pleiotropy in HumansCirculation, 2009
- Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): Comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromesAmerican Heart Journal, 2008
- Cholesterol lowering is more important than pleiotropic effects of statins for endothelial function in patients with dysglycaemia and coronary artery diseaseEuropean Heart Journal, 2008
- Safety and Efficacy of Statins in AsiansThe American Journal of Cardiology, 2007
- Rho Kinase Inhibition Improves Endothelial Function in Human Subjects With Coronary Artery DiseaseCirculation Research, 2006
- Differential effects of short-term lipid lowering with ezetimibe and statins on endothelial function in patients with CAD: clinical evidence for ‘pleiotropic’ functions of statin therapyEuropean Heart Journal, 2006
- Simvastatin Versus EzetimibeCirculation, 2005
- Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary DiseaseNew England Journal of Medicine, 2005
- Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary SyndromesNew England Journal of Medicine, 2004